Ucommune International Ltd. Form 6-K Summary
Reporting period: Form 6-K filed January 28, 2022, covering material events in January 2022. The filing reports a private financing completed January 26, 2022, and a Nasdaq continued-listing deficiency notice received January 24, 2022.
Business Context and Reporting Period
Ucommune International Ltd. is a foreign private issuer headquartered in Beijing, China, operating in the agile office space sector. This filing does not provide quarterly or annual operating results.
Financing and Key Financial Metrics
- Convertible debt: $3.0 million principal amount of 8% senior convertible debentures, maturing January 25, 2023.
- Interest: Cash interest is payable quarterly at 8% annually. The Company may elect to pay accrued interest in Class A ordinary shares at a 12% annual rate, subject to stated conversion-price provisions.
- Conversion terms: The debenture is convertible at the purchaser’s option into ordinary shares equal to 125% of principal, initially based on the lesser of $1.00 per share, subject to adjustments, or the lowest applicable 10-day volume-weighted average price.
- Warrants: The financing included Series A warrants for 3.75 million shares at $4.05 per share, Series B warrants for 18.75 million shares with an initial $1.00 exercise price and other adjustment features, and Series C warrants for 18.75 million shares at $4.05 per share, with staged vesting.
- Net proceeds: Approximately $2.6 million after a 10% purchaser discount and $65,000 of purchaser legal fees and expenses, excluding other offering expenses.
- Use of proceeds: Working capital.
- Liquidity covenant: The Company must maintain at least $1.0 million in cash or marketable securities while the debenture remains outstanding.
- Operating metrics: The filing does not provide clear values for revenue, profit or loss, operating cash flow, margins, total cash, total debt, or other period-specific financial metrics.
Material Changes and Financing Terms
- The Company incurred a $3.0 million convertible debt obligation and issued substantial warrant coverage in a private placement exempt from registration under Section 4(a)(2) and Rule 506 of Regulation D.
- The Company agreed to restrictions on additional debt, amendments to its organizational documents, certain security issuances and other corporate actions while the debenture is outstanding.
- The purchaser received a 36-month right to participate in certain future financings for up to 25% of the offering.
- The Company may redeem the debenture in cash at a 120% premium, subject to conditions, and may be required to issue additional Series A warrants upon optional redemption.
- The Company agreed to register the resale of shares underlying the debenture and warrants within specified deadlines. Failure to meet those deadlines can trigger cash liquidated damages equal to 2% of the purchaser’s subscription amount per month.
Nasdaq Listing Notice, Outlook and Risks
- Nasdaq notified the Company that its ordinary shares failed the $1.00 minimum closing bid-price requirement based on the 30 trading days from December 8, 2021 through January 21, 2022.
- The Company has until July 25, 2022, to regain compliance by maintaining a closing bid price of at least $1.00 for at least 10 consecutive business days.
- If compliance is not restored, the Company may qualify for additional time or face delisting. Management stated that it may consider measures including a reverse share split.
- Events of default under the debenture include payment defaults, covenant breaches, Nasdaq listing or eligibility issues, change-of-control or fundamental transactions, bankruptcy events, certain debt defaults and specified monetary judgments.
- Upon an event of default, the purchaser may require immediate cash payment of accelerated amounts, including premiums, liquidated damages, interest and other amounts owed.
- Conversion and exercise prices may be adjusted for stock splits, stock dividends, subsequent equity transactions, rights offerings and fundamental transactions. Delayed share delivery may result in liquidated damages and buy-in obligations.
- Key stated business risks include competition and demand in China’s agile office market, member retention, brand and service quality, business-partner relationships, regulatory and policy changes in China, financing needs and broader economic conditions.
Important Facts for Investors to Verify
- Whether the Company maintained the required $1.0 million minimum cash or marketable-securities balance.
- The outstanding principal, accrued interest and any conversions, redemptions or defaults under the debenture.
- The number of shares ultimately issuable upon conversion of the debenture and exercise of the warrants, including price adjustments.
- Whether the resale registration statement was filed and declared effective within the required periods, and whether registration-delay damages were incurred.
- Whether the Company regained Nasdaq’s minimum bid-price compliance by July 25, 2022, obtained additional time or faced delisting proceedings.
- The Company’s subsequent financial statements for revenue, profitability, cash flow, liquidity, debt and operating performance, which are not included in this filing.